Evidence map›Paper›PMID 19948998›Full record

ArticleThe Journal of general physiology2009

GABA transporter function, oligomerization state, and anchoring: correlates with subcellularly resolved FRET.

Fraser J Moss, P I Imoukhuede, Kimberly Scott, Jia Hu, Joanna L Jankowsky, Michael W Quick, Henry A Lester

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of general physiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. SLC6 transporter oligomerization.Journal of neurochemistry · 2021
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Fraser J MossDivision of Biology and 1,2 Program in Bioengineering, California Institute of Technology, Pasadena, CA 91125, USA.
P I Imoukhuede
Kimberly Scott
Jia Hu
Joanna L Jankowsky
Michael W Quick
Henry A Lester
California Institute of Technology · USUniversity of Southern California · US

Funding

NICOTINIC SYNAPSES, BIOPHYSICAL STUDIESR01NS011756 · NINDS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI LESTER, HENRY A. · 1985 to 2009
$3.4M
MONOAMINE TRANSPORTERS--STRUCTURE AND FUNCTIONR01DA009121 · NIDA · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI LESTER, HENRY A. · 1994 to 2007
$2.4M
GABA Transporters: Trafficking and RegulationR01DA010509 · NIDA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI QUICK, MICHAEL W. · 2001 to 2005
$1.4M
Interaction of ABeta &the alpha7 AChR in mouse AD modelK01AG026144 · NIA · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI JANKOWSKY, JOANNA L · 2004 to 2008
$622k
AMINE TRANSPORTERS--TRAFFICKING AND REGULATIONR29DA010509 · NIDA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI QUICK, MICHAEL W. · 1996 to 2000
$108k
NIA NIH HHS K01 AG026144NIDA NIH HHS DA-09121NIDA NIH HHS DA-10509NIDA NIH HHS R01 DA009121NIDA NIH HHS R01 DA010509NIDA NIH HHS R29 DA010509NINDS NIH HHS NS-11756NINDS NIH HHS R01 NS011756
6 · The paper itself

Abstract

The mouse gamma-aminobutyric acid (GABA) transporter mGAT1 was expressed in neuroblastoma 2a cells. 19 mGAT1 designs incorporating fluorescent proteins were functionally characterized by [(3)H]GABA uptake in assays that responded to several experimental variables, including the mutations and pharmacological manipulation of the cytoskeleton. Oligomerization and subsequent trafficking of mGAT1 were studied in several subcellular regions of live cells using localized fluorescence, acceptor photobleach Förster resonance energy transfer (FRET), and pixel-by-pixel analysis of normalized FRET (NFRET) images. Nine constructs were functionally indistinguishable from wild-type mGAT1 and provided information about normal mGAT1 assembly and trafficking. The remainder had compromised [(3)H]GABA uptake due to observable oligomerization and/or trafficking deficits; the data help to determine regions of mGAT1 sequence involved in these processes. Acceptor photobleach FRET detected mGAT1 oligomerization, but richer information was obtained from analyzing the distribution of all-pixel NFRET amplitudes. We also analyzed such distributions restricted to cellular subregions. Distributions were fit to either two or three Gaussian components. Two of the components, present for all mGAT1 constructs that oligomerized, may represent dimers and high-order oligomers (probably tetramers), respectively. Only wild-type functioning constructs displayed three components; the additional component apparently had the highest mean NFRET amplitude. Near the cell periphery, wild-type functioning constructs displayed the highest NFRET. In this subregion, the highest NFRET component represented approximately 30% of all pixels, similar to the percentage of mGAT1 from the acutely recycling pool resident in the plasma membrane in the basal state. Blocking the mGAT1 C terminus postsynaptic density 95/discs large/zona occludens 1 (PDZ)-interacting domain abolished the highest amplitude component from the NFRET distributions. Disrupting the actin cytoskeleton in cells expressing wild-type functioning transporters moved the highest amplitude component from the cell periphery to perinuclear regions. Thus, pixel-by-pixel NFRET analysis resolved three distinct forms of GAT1: dimers, high-order oligomers, and transporters associated via PDZ-mediated interactions with the actin cytoskeleton and/or with the exocyst.

Indexed as

AnimalsBiological TransportCell LineCell MembraneFluorescence Resonance Energy TransferGABA Plasma Membrane Transport Proteinsgamma-Aminobutyric AcidHumansMiceGABA Plasma Membrane Transport Proteinsgamma-Aminobutyric Acid

Identifiers

PMID19948998
PMCPMC2806419
OpenAlexW2137499349

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.